Spectroscopic Investigations, DFT Calculations, and Molecular Docking Studies of the Anticonvulsant (2<i>E</i>)-2-[3-(1<i>H</i>-Imidazol-1-yl)-1-phenylpropylidene]-<i>N</i>-(4-methylphenyl)hydrazinecarboxamide

<div>Binding pose diagrams of the (2<i>E</i>)-IPPMP molecule with its target protein.</div>

Journal of Spectroscopy

fig6

Figure 6

Figure 6: Spectroscopic Investigations, DFT Calculations, and Molecular Docking Studies of the Anticonvulsant (2<i>E</i>)-2-[3-(1<i>H</i>-Imidazol-1-yl)-1-phenylpropylidene]-<i>N</i>-(4-methylphenyl)hydrazinecarboxamide 

Figure 6 | Spectroscopic Investigations, DFT Calculations, and Molecular Docking Studies of the Anticonvulsant (2E)-2-[3-(1H-Imidazol-1-yl)-1-phenylpropylidene]-N-(4-methylphenyl)hydrazinecarboxamide 